Spero Therapeutics Inc (SPRO) is lower by 3.36% Monday In Premarket Trading

Spero Therapeutics Inc (SPRO) has fallen Monday morning, with the stock losing -3.36% in pre-market trading to 1.15. SPRO's short-term technical score of 27 indicates that the stock has traded less bullishly over the last month than 73% of stocks on the market. In the Biotechnology industry, which ranks 120 out of 146 industries, SPRO ranks higher than 42% of stocks. Spero Therapeutics Inc has risen 11.21% over the past month, closing at $1.05 on October 23. During this period of time, the stock fell as low as $1.00 and as high as $1.29. SPRO has an average analyst recommendation of Strong Buy. The company has an average price target of $7.00.

SPRO has an Overall Score of 48. Find out what this means to you and get the rest of the rankings on SPRO!

See Full SPRO Report

Spero Therapeutics Inc has a Long-Term Technical rank of 23. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 77% of the market scoring higher. In the Biotechnology industry which is number 130 by this metric, SPRO ranks better than 130% of stocks.

Important Dates for Investors in SPRO:

-Spero Therapeutics Inc is set to release earnings on 2024-02-11. Over the last 12 months, the company has reported EPS of $0.44. -We do not have a set dividend date for Spero Therapeutics Inc at this time. Click Here To Get The Full Report on Spero Therapeutics Inc (SPRO)